Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - TOTAL RECEIVABLES
Total Receivables KALV - KalVista Pharmaceuticals, Inc.
10.9 M
LAST VALUE
0.00%
2 YEAR CAGR
-0.80%
5 YEAR CAGR
0.00%
10 YEAR CAGR